Biomedical Engineering Reference
In-Depth Information
23. Cox JPD, Yamamoto K, Christie PT, Wooding C, Feest T, Flinter FA, Goodyer PR, Leumann
E, Neuhaus T, Reid C, Williams PF, Wrong O, Thakker RV (1999) Renal chloride channel,
CLCN5, mutations in Dent's disease. J Bone Miner Res 14(9):1536-1542
24. Schlingmann KP, Konrad M, Jeck N, Waldegger P, Reinalter SC, Holder M, Seyberth HrW,
Waldegger S (2004) Salt wasting and deafness resulting from mutations in two chloride
channels. N Engl J Med 350(13):1314-1319
25. Beer PD, Gale PA (2001) Anion recognition and sensing: the state of the art and future
perspectives. Angew Chem Int Ed 40(3):486-516
26. Gale PA, Quesada R (2006) Anion coordination and anion-templated assembly: highlights
from 2002 to 2004. Coord Chem Rev 250(23-24):3219-3244
27. Lavigne JJ, Anslyn EV (2001) Sensing a paradigm shift in the field of molecular recognition:
from selective to differential receptors. Angew Chem Int Ed 40(17):3118-3130
28. Herr RJ (2002) 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry
and synthetic methods. Bioorg Med Chem 10(11):3379-3393
29. Patani GA, LaVoie EJ (1996) Bioisosterism: a rational approach in drug design. Chem Rev
96(8):3147-3176
30. Olesen PH (2001) The use of bioisosteric groups in lead optimization. Curr Opin Drug Discov
Devel 4:471-478
31. Myznikov LV, Hrabalek A, Koldobskii GI (2007) Drugs in the tetrazole series. Chem
Heterocycl Compd 43(1):1-9
32. Nattel S (2005) Can losartan prevent new-onset atrial fibrillation in hypertensive patients more
effectively than atenolol? Nat Clin Pract Cardiovasc Med 2(7):332-333
33. Skulnick HI, Johnson PD, Aristoff PA, Morris JK, Lovasz KD, Howe WJ, Watenpaugh KD,
Janakiraman MN, Anderson DJ, Reischer RJ, Schwartz TM, Banitt LS, Tomich PK, Lynn JC,
Horng M-M, Chong K-T, Hinshaw RR, Dolak LA, Seest EP, Schwende FJ, Rush BD, Howard
GM, Toth LN, Wilkinson KR, Kakuk TJ, Johnson CW, Cole SL, Zaya RM, Zipp GL, Possert
PL, Dalga RJ, Zhong W-Z, Williams MG, Romines KR (1997) Structure-based design of
nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyranones. J Med
Chem 40(7):1149-1164
34. Reddy NS, Mallireddigari MR, Cosenza S, Gumireddy K, Bell SC, Reddy EP, Reddy MVR
(2004) Synthesis of new coumarin 3-(
N
-aryl) sulfonamides and their anticancer activity.
Bioorg Med Chem Lett 14(15):4093-4097
35. Lobb KL, Hipskind PA, Aikins JA, Alvarez E, Cheung Y-Y, Considine EL, De Dios A, Durst
GL, Ferritto R, Grossman CS, Giera DD, Hollister BA, Huang Z, Iversen PW, Law KL, Li T,
Lin H-S, Lopez B, Lopez JE, Cabrejas LMM, McCann DJ, Molero V, Reilly JE, Richett ME,
Shih C, Teicher B, Wikel JH, White WT, Mader MM (2004) Acyl sulfonamide anti-
proliferatives: benzene substituent structure‚ activity relationships for a novel class of
antitumor agents. J Med Chem 47(22):5367-5380
36. Stansfield I, Pompei M, Conte I, Ercolani C, Migliaccio G, Jairaj M, Giuliano C, Rowley M,
Narjes F (2007) Development of carboxylic acid replacements in indole-
N
-acetamide
inhibitors of hepatitis C virus NS5B polymerase. Bioorg Med Chem Lett 17(18):5143-5149
37. Hu X, Sun J, Wang H-G, Manetsch R (2008) Bcl-xl-templated assembly of its own protein-
protein interaction modulator from fragments decorated with thio acids and sulfonyl azides.
J Am Chem Soc 130(42):13820-13821
38. Mahnke DJ, McDonald R, Hof F (2007) A shape-dependent hydrophobic effect for tetrazoles.
Chem Commun (36):3738-3740
39. Tominey A, Andrew D, Oliphant L, Rosair GM, Dupre J, Kraft A (2006) Supramolecular
binding of protonated amines to a receptor microgel in aqueous medium. Chem Commun
(23):2492-2494
40. Peters L, Froehlich R, Boyd ASF, Kraft A (2001) Noncovalent interactions between tetrazole
and an N, N-diethyl-substituted benzamidine. J Org Chem 66(10):3291-3298
41. Khazaei A, Manesh AA (2006) Selective oxidation of oximes to carbonyl compounds using
n-bromo-n-benzoyl-4-toluenesulfonamide. Mendeleev Commun 16(2):109-111
Search WWH ::
Custom Search